Cash Position: GeoVax reported cash balances of $3,093,862 at June 30, 2025, as compared to $5,506,941 at December 31, 2024. During July 2025, the Company completed a public offering of common stock ...

A new study has uncovered a distinct pattern of immune-related genes in hepatobiliary cancers, setting them apart from other gastrointestinal tumors.

In a new paper, a team from Yale and Fred Hutch has found autoantibody reactivity could predict cancer patients' response to ...

Researchers saw some cases where a patient’s own autoantibodies boosted likelihood of responding to checkpoint blockade.

A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly ...

The research highlights the potential of these immune proteins to enhance the effectiveness of checkpoint inhibitors in certain individuals.

Poor vaccine response in dialysis was linked to heart failure and low albumin, not dialysis-specific factors, highlighting ...

A new dual vaccine for COVID-19 and flu shows strong immune responses and good safety in adults over 50, offering a potential ...

Using detailed genetic analysis and manipulation, researchers show that continuous T-bet expression in these cells is key to preserving the protective memory response.

Osivax publishes phase 2a results of OVX836-004 study; supports co-administration of OVX836 with seasonal flu vaccine: Lyon, France Saturday, July 12, 2025, 18:00 Hrs [IST] Osivax ...

At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the ...

Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 pandemic. Prophylactic cancer vaccines have prevented several malignancies by ...